Roswell Park Comprehensive Cancer Center

MIAMI — Saby George, MD, FACS, offered background in special considerations that should be taken when treating patients with metastatic renal cell carcinoma at the International Kidney Cancer Symposium.

The FDA’s approval of tisagenlecleucel for the treatment of children and young adults with relapsed or refractory B-cell acute lymphoblastic leukemia represents a watershed moment for cancer care.

The FDA granted orphan drug designation to SurVaxM for the treatment of patients with glioblastoma, according to the agent’s manufacturer.

Adding flavors and intensifying the power of e-cigarettes substantially increases toxicity, according to study results published in Tobacco Control.

CHICAGO — Candace Johnson, PhD, president and CEO of Roswell Park Cancer Institute, discusses how research in immunotherapy and genomics can lead to tailored personalized treatments at the ASCO Annual Meeting.

CHICAGO — Candace Johnson, PhD, president and CEO of Roswell Park, offers background on the potential use of CimaVax, a vaccine developed in Cuba that immunizes against epidermal growth factor, at the ASCO Annual Meeting.

The American Association for Cancer Research Annual Meeting focused on a lot of new discoveries and novel approaches about how to use the body’s immune system to treat patients with cancer.

NEW ORLEANS — Multivitamin supplement use appeared associated with a reduced risk for chemotherapy-induced peripheral neuropathy among patients with breast cancer, according to study results Gary Zirpoli, PhD, research fellow at Roswell Park Cancer Institute, presented at the American Association for Cancer Research Annual Meeting.

Rikki Cannioto, PhD, EdD, of Roswell Park Comprehensive Cancer Center, discussed her study linking physical activity before and after breast cancer treatment to reduced recurrence and mortality rates among patients with high-risk disease.